TVT Revenue and Profits Up, Strengthened by Summer Fever Camera Boom
Many Western users may be unfamiliar with TVT, a Shenzhen company that OEMs for companies including Avycon, Speco, InVid, and Vitek. However, TVT has had a strong 2020.
In this note, IPVM examines TVT's 2020 performance thus far, its Q3 2020 financial disclosures, and what this means for TVT going forward, including:
- Solid 2020 performance Q1-Q3 despite COVID-19
- Q3 2020 revenue and profit growth analyzed
- TVT overseas vs domestic business breakdown
- 2020 financial performance boosted by fever camera products, TVT says
- Recent fever camera demand slowdown impact on TVT
- US 2020 imports analyed and top buyers examined
- NDAA opportunities for TVT
- TVT comments on future strategy
- Market response positive to Q3 2020 results
TVT **********
*** ** * ********, ***** ***** surveillance **************** ~$** ******* ** **** *******. *** ******* ************* ** ********* **** *** ********* **** ***** its *** ***** ** ***** *******. TVT ******** *** ***** ****** ******** earlier ** **** **** *** *****-** epidemic ***** *******, ********* ****** **************** ** *****, ******, *** ***** as **** ** ****** ****** ************** ************ *** ******* ******** (***).
Solid **** *********** **** *** ******* *****-**
***** *** ***** ************ ******** *** a ***** **** ***** *** ** COVID-19, *** ****** ****** **** ****. Q1 *** ************ *** *** *** industry, **** ******** ***********************'* ***** ********** -**.**% *** -*.**% YoY, ************.
*******, *** ***** *** **.**% *** revenue ****** ** ** **** ***** COVID-19 ****** ****** *** *****, ******** production ***** *** ******* **********.
** ***-****, ** **** ******* *** up ~*% ****** **** ******** ** Q2:
Q3 **** ******* ***** **% *** ** $**.* ******* ***, ******* **** ***% ** $*.* ******* ***
*** **** * ****** ~**% ** Q3 *** **** **** ** ******* in ** **** **** ** *** in ** *** ** **** ********.
*** *** **** *** *** ****** margins ************ ******** **** *** **** few *****.
***** ***** ************* ************************* **** ******** ** **, ********* positive *** ******* ****** (~**%), *** not ** *** ****** ** ***'* growth (~**%). *******, ***'* ******* **** continued ** **** ************* (~***%) ** Q3 ***** ***** *************' **** ****** due ** ******* ***** ****** ******.
*******, ***** ** ~*** ****** **** TVT *** ********* ** ~*** ****** so ** ** ****** *** *** to **** ** ********** *****.
Most ** ******* ************ ** ******** *****
~**% ** ***'* ***** **** **** its ******** ********, ** ** ************ on *** *** ******** ******** ****** than ******* ********. ** *** **** 3 *****, *** *** ************ **** the **** ******** (~**-**% ) ** its ******* ********, ** ******* ********* on ******** ******** ** *** *********** a ****** ****** ** *****-** ********* fever ****** ***** ******.
********* ** *********** ****** **/*, *** "**** *******" *** operated ** ****** **-** **** **** the "**, ******, *** *****, ***."
***'* ***** ** *** ** **** 38% ** **-** **** *** ********* just **** * ******* ** *** sales ** *** ******.
Financial *********** ******* ** ***** ****** ********
***'* ******** ********* *********** ** **-** 2020 *** "****** **** *** ** its ******* ** ******* ******** *********** measurement ******** (红外测温产品) ***, ** * result, ****** ******* ***** ****** *******," TVT ********* *** ****** ********* ******. ** **** **** ***** ************* who **** ********* **** * ***** in ***** ****** ******, ***'* ** 2020 ******* *** ********* ~* ********** points *** **** *** ******* *** its ******** ****** (**** ~**% ** 38%). **** ** * *********** ******** resulting **** ****** ***** ** **** margin ***** ****** ********. *** *** not ****** ******** ******* ** *** H1 **** ****** *** *** *** report ******* *** ** ****.
Fever ****** ****** ******** ******* *** ***
***** ** ****** ** ******* ******** in ***** ****** ***** *** ***** manufacturers *********,****, ************, *** *** *** ********* ** whether *** ******* *** ******* *** has ******** ** * **** **********, pre-epidemic *****. *******, ***'* ** **** profits **** ~***% ***, *** ** is ******* ******* **** ******** ** profits ** ***** **** ***** ****** sales ** **** *******.
Significant ** ******* ** **** ****** **** ***
******* *****-**, ***'* ** *** ******** has **** ****** **** ****, ****** records ****. ********* ** ********* ****** records, ***'* * ******* ********* ** weight *** ****** *** *****, ******** by ***** *** *****.
TVT ***** ** ************* **** ****
*** *** ****** ****** ******** ** the ** **** ***** ******* ** well ** *** *** ******* *** an***************. *******, ***** ****** ** ********, as *** *** **** ********* ** use ****** ********* ** ******* ******** (such ** ******** ******), *** ********* ** ******* ** the **** *** ** ****.
TVT ******** ** ****** ********: "******** ** ***** ** **, *****, *** *************"
***** *** ******** ** ******* ** the ******* ***** ** *** ***** camera *****, *** **** **** **** have **** "******* *********" ** **, cloud, *** ************* *** **** ******** to ***** ** ***** ****** ** the ****** ** **** *********** ** the ********:
*** *** **** ******* ********* **** the ** (******/******* **************, *** *** Facial ***********), ***** *** ***** ******** over *** **** *****, *** **** will ******** ** ** *** ***** in *** ***** ** ****, ** want ** **** **** *** ******* could ****** **** ** **** ** the *********** ** ***** ** *** technology.
Market ******** ******** ** ** **** *******
*** ****** ******* ********** ** ***'* Q3 **** *******, **** *** ***** trading ** ~**% ** ****** **/**, the ***** **** *** ** ******* after ******* **** ********* ** ****** 10/23. *******, *** ** ***** ******* below *** **** ** ****** ****. Nevertheless, *** ** ******* ** ~**% from *** ********* ** ****.